Consistent and differential genetic aberrations between esophageal dysplasia and squamous cell carcinoma detected by array comparative genomic hybridization

Clinical Cancer Research

Volumn 19, Issue 21, 2013, Pages 5867-5878

  Shi, Zhi Zhou ^a   Shang, Li ^a   Jiang, Yan Yi ^a   Hao, Jia Jie ^a   Zhang, Yu ^a   Zhang, Tong Tong ^a   Lin, De Chen ^a   Liu, Shu Guang ^a   Wang, Bo Shi ^a   Gong, Ting ^a   Zhan, Qi Min ^a   Wang, Ming Rong ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MICRORNA;

ADVANCED CANCER; ANO1 GENE; ARTICLE; CANCER STAGING; CCND1 GENE; CDKN2A GENE; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN KYSE30; CELL STRAIN KYSE510; CHROMOSOME 11Q; CHROMOSOME 7P; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS BIOPSY; ESOPHAGUS DYSPLASIA; ESOPHAGUS RESECTION; GENE; GENE AMPLIFICATION; GENE DELETION; GENE DOSAGE; GENE IDENTIFICATION; GENE LOSS; GENE OVEREXPRESSION; GENETIC DISORDER; HISTOPATHOLOGY; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; HUMANS; PRECANCEROUS CONDITIONS;

EID: 84887127381     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-3753     Document Type: Article

References (40)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002.CA Cancer J Clin 2005;55: 74-108.
2. He YT, Hou J, Chen ZF, Qiao CY, Song GH, Meng FS, et al. Decrease in the esophageal cancer incidence rate in mountainous but not level parts of Cixian County, China, over 29 years. Asian Pac J Cancer Prev 2005;6: 510-4.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59: 225-49.
4. Ma X, Chen K, Huang S, Zhang X, Adegboyega PA, Evers BM, et al. Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis 2005;26: 1698-705.
5. Yen CC, Chen YJ, Chen JT, Hsia JY, Chen PM, Liu JH, et al. Comparative genomic hybridization of esophageal squamous cell carcinoma: correlations between chromosomal aberrations and disease progression/prognosis. Cancer 2001;92: 2769-77.
6. Hirasaki S, Noguchi T, Mimori K, Onuki J, Morita K, Inoue H, et al. BAC clones related to prognosis in patients with esophageal squamous carcinoma: an array comparative genomic hybridization study. Oncologist 2007;12: 406-17.
7. Ueno T, Tangoku A, Yoshino S, Abe T, Toshimitsu H, Furuya T, et al. Gain of 5p15 detected by comparative genomic hybridization as an independent marker of poor prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2002;8: 526-33.
8. Shi ZZ, Liang JW, Zhan T, Wang BS, Lin DC, Liu SG, et al. Genomic alterations with impact on survival in esophageal squamous cell carcinoma identified by array comparative genomic hybridization. Genes Chromosomes Cancer 2011;50: 518-26.
9. Wang G, Brennan C, Rook M, Wolfe JL, Leo C, Chin L, et al. Balanced- PCR amplification allows unbiased identification of genomic copy changes in minute cell and tissue samples. Nucleic Acids Res 2004;32:e76.
10. Su H, Hu N, Yang HH, Wang C, Takikita M, Wang QH, et al. Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes. Clin Cancer Res 2011;17: 2955-66.
11. Zhang X, Lin P, Zhu ZH, Long H, Wen J, Yang H, et al. Expression profiles of early esophageal squamous cell carcinoma by cDNA microarray. Cancer Genet Cytogenet 2009;194: 23-9.
12. Ogawa R, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Katada T, et al. Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med Mol Morphol 2009;42: 102-9.
13. Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, et al. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep 2010;23: 1625-33.
14. Shinomiya T, Mori T, Ariyama Y, Sakabe T, Fukuda Y, Murakami Y, et al. Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DPI gene in the 13q34 amplicon. Genes Chromosomes Cancer 1999;24: 337-44.
15. Pack SD, Karkera JD, Zhuang Z, Pak ED, Balan KV, Hwu P, et al. Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations. Genes Chromosomes Cancer 1999;25: 160-8.
16. Tada K, Oka M, Hayashi H, Tangoku A, Oga A, Sasaki K. Cytogenetic analysis of esophageal squamous cell carcinoma cell lines by comparative genomic hybridization: relationship of cytogenetic aberrations to in vitro cell growth. Cancer Genet Cytogenet 2000;117: 108-12.
17. Noguchi T, Kimura Y, Takeno S, Chujo M, Uchida Y, Mueller W, et al. Chromosomal imbalance in esophageal squamous cell carcinoma: 3q gain correlates with tumor progression but not prognostic significance. Oncol Rep 2003;10: 1393-400.
18. Ishizuka T, Tanabe C, Sakamoto H, Aoyagi K, Maekawa M, Matsukura N, et al. Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH. Biochem Biophys Res Commun 2002;296: 152-5.
19. Kwong D, Lam A, Guan X, Law S, Tai A, Wong J, et al. Chromosomal aberrations in esophageal squamous cell carcinoma among Chinese: gain of 12p predicts poor prognosis after surgery. Hum Pathol 2004;35: 309-16.
20. Qin YR, Wang LD, Fan ZM, Kwong D, Guan XY. Comparative genomic hybridization analysis of genetic aberrations associated with development of esophageal squamous cell carcinoma in Henan, China. World J Gastroenterol 2008;14: 1828-35.
21. Sakai N, Kajiyama Y, Iwanuma Y, Tomita N, Amano T, Isayama F, et al. Study of abnormal chromosome regions in esophageal squamous cell carcinoma by comparative genomic hybridization: relationship of lymph node metastasis and distant metastasis to selected abnormal regions. Dis Esophagus 2010;23: 415-21.
22. Kawakubo H, Ozawa S, Ando N, Kitagawa Y, Mukai M, Ueda M, et al. Alterations of p53, cyclin D1, and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma. Oncol Rep 2005;14: 1453-9.
23. Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 2009;41: 1238-42.
24. Kim SG, Hong SJ, Kwon KW, Jung SW, Kim WY, Jung IS, et al. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia]. Korean J Gastroenterol 2006;48: 269-76.
25. Wang GQ, Abnet CC, Shen Q, Lewin KJ, Sun XD, Roth MJ, et al. Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut 2005;54: 187-92.
26. Yang L, Wang LS, Chen XL, Gatalica Z, Qiu S, Liu Z, et al. Hedgehog signaling activation in the development of squamous cell carcinoma and adenocarcinoma of esophagus. Int J Biochem Mol Biol 2012;3: 46-57.
27. Adams L, Roth MJ, Abnet CC, Dawsey SP, Qiao YL, Wang GQ, et al. Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma. Cancer Prev Res 2008;1: 357-61.
28. Hao JJ, Shi ZZ, Zhao ZX, Zhang Y, Gong T, Li CX, et al. Characterization of genetic rearrangements in esophageal squamous carcinoma cell lines by a combination of M-FISH and array-CGH: further confirmation of some split genomic regions in primary tumors. BMC Cancer 2012;12: 367.
29. Katoh H, Shibata T, Kokubu A, Ojima H, Loukopoulos P, Kanai Y, et al. Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome. J Hepatol 2005;43: 863-74.
30. Ying J, Shan L, Li J, Zhong L, Xue L, Zhao H, et al. Genome-wide screening for genetic alterations in esophageal cancer by aCGH identifies 11q13 amplification oncogenes associated with nodal metastasis. PLoS ONE 2012;7:e39797.
31. Baudis M, Cleary ML. Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics 2001;17: 1228-9.
32. Baudis M. Progenetix oncogenomic online resource 2012 [cited May 31, 2013]. Available from: www.progenetix.net.
33. Sawey ET, Chanrion M, Cai C, Wu G, Zhang J, Zender L, et al. Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by oncogenomic screening. Cancer Cell 2011;19: 347-58.
34. Brown LA, Kalloger SE, Miller MA, Shih Ie M, McKinney SE, Santos JL, et al. Amplification of 11q13 in ovarian carcinoma. Genes Chromosomes Cancer 2008;47: 481-9.
35. Kirkegaard T, Nielsen KV, Jensen LB, Campbell FM, Muller S, Tovey SM, et al. Genetic alterations of CCND1 and EMSY in breast cancers. Histopathology 2008;52: 698-705.
36. Hu N, Wang C, Ng D, Clifford R, Yang HH, Tang ZZ, et al. Genomic characterization of esophageal squamous cell carcinoma from a highrisk population in China. Cancer Res 2009;69: 5908-17.
37. Sugimoto T, Seki N, Shimizu S, Kikkawa N, Tsukada J, Shimada H, et al. The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma. Genes Chromosomes Cancer 2009;48: 132-42.
38. Liu W, Lu M, Liu B, Huang Y, Wang K. Inhibition of Ca(2+)-activated Cl(-) channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma. Cancer Lett 2012;326: 41-51.
39. Ayoub C, Wasylyk C, Li Y, Thomas E, Marisa L, Robe A, et al. ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines. Br J Cancer 2010;103: 715-26.
40. Duvvuri U, Shiwarski DJ, Xiao D, Bertrand C, Huang X, Edinger RS, et al. TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer Res 2012;72: 3270-81.